Pallavi Saha

Pallavi Saha

Auto-generated profile, based on publicly available information

Pallavi Saha

Department of Pharmaceutical Engg. And Tech., IIT-Banaras Hindu University, Varanasi, UP, 221005, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PSPallavi Saha
Pallavi Saha
SDSamarpita Das
Samarpita Das
HIHarish K. Indurthi
Harish K. Indurthi
RKRohit Kumar
Rohit Kumar
ARArnab Roy
Arnab Roy
DSDeepak K Sharma
Deepak K Sharma
Cytochrome bd (cyt-bd) oxidase, one of the two terminal oxidases in the Mycobacterium tuberculosis (Mtb) oxidative phosphorylation pathway, plays an indispensable role in maintaining the functionality of the metabolic pathway under stressful conditions.

1 April 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PSPallavi Saha
Pallavi Saha
SSShashikanta Sau
Shashikanta Sau
DKDr. Nitin Pal Kalia
Dr. Nitin Pal Kalia
DSDeepak K Sharma
Deepak K Sharma
Mycobacterium tuberculosis (Mtb) type II NADH dehydrogenase (NDH-2) transports electrons into the mycobacterial respiratory pathway at the cost of reduction of NADH to NAD+ and is an attractive drug target.

30 August 2023 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PKParampreet Kour
Parampreet Kour
PSPallavi Saha
Pallavi Saha
SBSrija Bhattacharya
Srija Bhattacharya
DKDiksha Kumari
Diksha Kumari
ADAbhipsa Debnath
Abhipsa Debnath
KSKuljit Singh
Kuljit Singh
Leishmaniasis, one of the neglected diseases, ranks second to malaria in the cause of parasitic mortality and morbidity. The present chemotherapeutic regimen faces the limitations of drug resistance and toxicity concerns, raising a great need to develop new chemotherapeutic leads that are orally administrable, potent, non-toxic, and cost-effective. Several research groups came forward to fill this therapeutic gap with new classes of active compounds against leishmaniasis, one such being 3,3′-diindolylmethane (DIM) derivatives. We tried to link this concept with another promising approach of glycoconjugation to study how glycosylated groups work differently from non-glycosylated ones. In the present study, a series of 3,3′-DIM derivatives have been synthesized and screened for their anti-leishmanial potency on Leishmania donovani promastigotes. Next, we synthesized the β-N,N′ glycoside of potent compound 3d using indole–indoline conversion, Fischer-type glycosylation, 2,3-dichloro-5,6-dicyano-1,4-benzoquionone (DDQ) oxidation, and molecular iodine catalyzed coupling with a suitable aldehyde in reasonable overall yield. The biological evaluation revealed that glycosides had reduced cytotoxic effects on the J774A.1 macrophage cell line. The enzyme inhibition study confirms that the glycoside derivatives have significant inhibitory activity against the leishmanial topoisomerase IB enzyme. Molecular docking further displayed the better binding efficiency of glycoside 13 with the target enzyme, suggesting the involvement of more H-bond interactions in the case of glycosides as compared to free drugs. Therefore, this work helps in proposing the fact that the addition of sugar moieties adds some favorable characteristics to free inhibitors, making it a promising approach for future clinical diagnostic and therapeutic applications, which can prove to be a valuable arsenal in combating such neglected diseases.

10 October 2023 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
PSPallavi Saha
Pallavi Saha
RKRohit Kumar
Rohit Kumar
SDSamarpita Das
Samarpita Das
TAToufik Ansari
Toufik Ansari
Arindam IndraArindam Indra
Arindam Indra
DSDeepak K Sharma
Deepak K Sharma
A visible light induced C-3 thiocyanation of imidazo[1,2- a ]pyridines and various other heterocycles (benzo[ d ]imidazo[2,1- b ]thiazoles, indoles, azaindoles, and anilines) was performed using a naphthalimide based photoredox catalyst.

15 August 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
PSPallavi Saha
Pallavi Saha
PKParampreet Kour
Parampreet Kour
RKRohit Kumar
Rohit Kumar
DSDeepak K Sharma
Deepak K Sharma

1 April 2024 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
PSPallavi Saha
Pallavi Saha
SDSamarpita Das
Samarpita Das
HIHarish K. Indurthi
Harish K. Indurthi
RKRohit Kumar
Rohit Kumar
DSDeepak K Sharma
Deepak K Sharma
A visible light-mediated, photocatalyst-free, persulfate-promoted approach has been explored for regioselective C-1 thiocyanation of imidazo[1,5- a ]pyridines.